| 摘要 |
The delivery of biopharmaceutical and other therapeutic agents parenterally to an animal via a minimally invasive, low pain administration is provided. The agents are delivered to the patient via, e.g., the epidermal, dermal, or subcutaneous layer of the skin in a concentrated form of injectable glucagon that is dissolved in a pharmaceutically acceptable carrier. |
| 申请人 |
XERIS PHARMACEUTICALS, INC.;THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODYCORPORATE;PRESTRELSKI, STEVEN;FANG, WEI-JIE;CARPENTER, JOHN F.;KINZELL, JOHN |
发明人 |
PRESTRELSKI, STEVEN;FANG, WEI-JIE;CARPENTER, JOHN F.;KINZELL, JOHN |
